The Pennant Group (NASDAQ:PNTG – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.01), FiscalAI reports. The Pennant Group had a net margin of 3.05% and a return on equity of 10.43%. The business had revenue of $302.25 million during the quarter, compared to analyst estimates of $299.34 million.
The Pennant Group Trading Down 8.7%
Shares of The Pennant Group stock traded down $3.49 during trading hours on Friday, hitting $36.51. The company’s stock had a trading volume of 928,656 shares, compared to its average volume of 304,506. The company has a market capitalization of $1.28 billion, a PE ratio of 36.88, a price-to-earnings-growth ratio of 2.87 and a beta of 1.33. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.20 and a quick ratio of 1.20. The stock has a 50 day moving average of $40.19 and a 200 day moving average of $35.66. The Pennant Group has a 12 month low of $23.50 and a 12 month high of $44.24.
Wall Street Analysts Forecast Growth
PNTG has been the subject of several recent research reports. Truist Financial upped their target price on shares of The Pennant Group from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Weiss Ratings upgraded The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, August 19th. Wells Fargo & Company lifted their price objective on The Pennant Group from $45.00 to $46.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 11th. Oppenheimer upped their price objective on The Pennant Group from $47.00 to $50.00 and gave the company an “outperform” rating in a report on Thursday. Finally, Royal Bank Of Canada upped their price objective on The Pennant Group from $44.00 to $48.00 and gave the company an “outperform” rating in a report on Friday. Six equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $48.00.
Get Our Latest Stock Report on The Pennant Group
The Pennant Group Company Profile
The Pennant Group, Inc is a healthcare services company that operates home health, hospice and senior living businesses in the United States. Through its affiliated agencies and communities, the company provides skilled nursing, physical, occupational and speech therapy, personal care, hospice and palliative services, assisted living, and other support for older adults and individuals recovering from illness or injury.
Pennant’s home health and hospice operations serve patients in their homes and other residential settings, while its senior living segment operates communities that provide assisted living and related services.
See Also
- Five stocks we like better than The Pennant Group
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.
